Completely revised and updated to take into account the new taxonomy and grouping changes made by the International Committee on Taxonomy of Viruses in their 8th Report, The Dictionary of Virology provides an authoritative and concise list of all viruses affecting vertebrate species, from humans to fish. - Includes the new viruses of medical or veterinary importance that have emerged since 2001, such as the new human coronaviruses, SARS and NL63 and a new subtype of influenza (H1N2) - Includes new terms in virology - Extensive cross-referencing and illustrative tables further enhance the use of this book

Although many books have been published on various aspects of human, animal, and plant parasitology, as well as the public health problems associated with parasites, none to date has offered a comprehensive glossary for those confronted with the discipline's exceptionally extensive terminology. To meet this need requires a dedicated text that can h

This third edition of A Dictionary of Virology offers an authoritative, concise, and up-to-date list of all viruses affecting vertebrate species, from humans to fish. It has been completely revised since the 1997 edition to include 25% more entries, including many completely new viruses. The entries have been restructured so that all viruses are listed and classified in accordance with the standards set by the 7th Report of the ICTV. The extensive cross-referencing and illustrative tables further enhance the utility of this reference.

In the past half century, deadly disease outbreaks caused by novel viruses of animal origin - Nipah virus in Malaysia, Hendra virus in Australia, Hantavirus in the United States, Ebola virus in Africa, along with HIV (human immunodeficiency virus), several influenza subtypes, and the SARS (sudden acute respiratory syndrome) and MERS (Middle East respiratory syndrome) coronaviruses - have underscored the urgency of understanding factors influencing viral disease emergence and spread. Emerging Viral Diseases is the summary of a public workshop hosted in March 2014 to examine factors driving the appearance, establishment, and spread of emerging, re-emerging and novel viral diseases; the global health and economic impacts of recently emerging and novel viral diseases in humans; and the scientific and policy approaches to improving domestic and international capacity to detect and respond to global outbreaks of infectious disease. This report is a record of the presentations and discussion of the event.

This Third, Revised Edition of a unique, encyclopaedic reference work covers the whole field of pure and applied microbiology and microbial molecular biology, from A to Zythia.

This multidisciplinary reference takes the reader through all four major phases of interdisciplinary inquiry: adequate conceptualization, rigorous formulation, substantive interpretation, and innovative implementation. The text introduces a novel synthetic paradigm of public health reasoning and epidemic modelling, and implements it with a study of the infamous 14th century AD Black Death disaster that killed at least one-fourth of the European population.

On October 17, 2014, spurred by incidents at U.S. government laboratories that raised serious biosafety concerns, the United States government launched a one-year deliberative process to address the continuing controversy surrounding so-called "gain-of-function" (GOF) research on respiratory pathogens with pandemic potential. The gain of function controversy began in late 2011 with the question of whether to publish the results of two experiments involving H5N1 avian influenza and continued to focus on certain research with highly pathogenic avian influenza over the next three years. The heart of the U.S. process is an evaluation of the potential risks and benefits of certain types of GOF experiments with influenza, SARS, and MERS viruses that would inform the development and adoption of a new U.S. Government policy governing the funding and conduct of GOF research. Potential Risks and Benefits of Gain-of-Function Research is the summary of a two-day public symposia on GOF research. Convened in December 2014 by the Institute of Medicine and the National Research Council, the main focus of this event was to discuss principles important for, and key considerations in, the design of risk and benefit assessments of GOF research. Participants examined the underlying scientific and technical questions that are the source of current discussion and debate over GOF research involving pathogens with pandemic potential. This report is a record of the presentations and discussion of the meeting.